Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Business

Lawmakers ask Mark Zuckerberg to show how Facebook, Instagram are addressing illicit drug ads

by August 16, 2024
August 16, 2024
Lawmakers ask Mark Zuckerberg to show how Facebook, Instagram are addressing illicit drug ads

A bipartisan group of lawmakers sent Meta CEO Mark Zuckerberg a letter on Thursday expressing concern that the company is failing to prevent illicit drug advertisements from running on its platform.

The House members cited recent reports from The Wall Street Journal and nonprofit Tech Transparency Project, which uncovered a flood of ads on Facebook and Instagram that pointed users to third-party services where they could purchase prescription pills, cocaine and other recreational drugs.

“On March 16, 2024, the Wall Street Journal reported that U.S. federal prosecutors have been investigating Meta for facilitating the sale of illicit drugs,” the lawmakers wrote. “Instead of quickly addressing the issue and fully removing the illicit content, on July 31, 2024, the Wall Street Journal again reported that Meta was ‘“running ads on Facebook and Instagram that steer users to online marketplaces for illegal drugs.’”

Most troubling, they wrote, is that Meta continues to run ads despite the company facing an investigation by U.S. federal prosecutors “for facilitating the sale of illicit drugs.”

The letter’s 19 authors include Reps. Tim Walberg (R-Mich.), Gus Bilirakis (R-Fla.), Kathy Castor (D-Fla.) and Lori Trahan (D-Mass.). They noted that the illicit drug ads were “approved and monetized by Meta” and that they were not hidden on the dark web or private social media pages. Media outlets and researchers could easily find the ads, which contained “contained blatant references to illegal drugs,” while Meta’s internal processes apparently missed them.

“Time and time again we have heard from Meta that users come to your platforms because they like the personalization and experiences you provide, and you use sensitive personal information to direct such personalization through content and advertisements,” the lawmakers wrote. “We in Congress, on multiple occasions, have worked to establish data privacy and security protections for Americans but have, in each instance, been met with friction and opposition from Meta with claims that we would drastically disrupt this personalization you are providing.”

They sent Zuckerberg a list of 15 questions intended to uncover more details about how Meta is addressing the problem, and asked him to respond by Sept. 6.

Meta confirmed receipt of the letter and said it plans to respond. The company shared with CNBC the same statement it gave the Journal for its initial story.

“Drug dealers are criminals who work across platforms and communities, which is why we work with law enforcement to help combat this activity. Our systems are designed to proactively detect and enforce against violating content, and we reject hundreds of thousands of ads for violating our drug policies. We continue to invest resources and further improve our enforcement on this kind of content. Our hearts go out to those suffering from the tragic consequences of this epidemic — it requires all of us to work together to stop it.”

This post appeared first on NBC NEWS
previous post
Biden says admin is ‘closer than we’ve ever been’ to cease-fire deal in Middle East
next post
Expert dismisses Russian commander’s ‘highly unlikely’ claim about crucial military advantage over US

Related Posts

Boeing says it’s progressing on safety reforms and...

April 3, 2025

Some consumers are punting big purchases like pools...

May 19, 2024

Target, McDonald’s and others are offering value as...

May 24, 2024

Trump Media shares end week down nearly 20%,...

April 13, 2024

Delta CEO offers employees free flights after CrowdStrike-Microsoft...

August 5, 2024

Mike Tyson, Jake Paul fight was the most...

November 20, 2024

FDA declares cucumber-linked Salmonella outbreak over after 155...

August 26, 2024

What is Apple’s ‘SOS mode’? iPhone feature lets...

February 27, 2024

Amazon’s Nova AI agent launch puts it up...

March 31, 2025

Amazon’s Prime Day a ‘major’ cause of worker...

July 17, 2024

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Latest News

    • Israel releases conversations with Gaza residents amid criticisms of aid delivery system

      July 1, 2025
    • Iran, following Trump strikes, says ‘the doors of diplomacy will never slam shut’

      July 1, 2025
    • Elon Musk’s attacks on Trump’s ‘big, beautiful bill’ have ‘no basis,’ says No 2 House Republican

      July 1, 2025
    • Trump says DOGE ‘monster’ may have to ‘eat Elon’ as Musk vows primary ads for lawmakers who cross him on BBB

      July 1, 2025
    • Senate parliamentarian OKs ban on Planned Parenthood federal funding in Trump megabill

      July 1, 2025
    • 4 Senate amendments to Trump megabill that failed — and 1 that passed

      July 1, 2025

    Categories

    • Business (1,288)
    • Politics (6,227)
    • Stocks (904)
    • World News (460)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved